Kerbl R - Search Results

1

Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.

Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, Urban C. Strenger V, et al. Among authors: kerbl r. Pediatr Blood Cancer. 2007 May;48(5):504-9. doi: 10.1002/pbc.20888. Pediatr Blood Cancer. 2007. PMID: 16732582

2

Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.

Kerbl R, Urban CE, Ambros IM, Dornbusch HJ, Schwinger W, Lackner H, Ladenstein R, Strenger V, Gadner H, Ambros PF. Kerbl R, et al. J Clin Oncol. 2003 Nov 15;21(22):4228-34. doi: 10.1200/JCO.2003.10.168. J Clin Oncol. 2003. PMID: 14615452

3

"Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening.

Fritsch P, Kerbl R, Lackner H, Urban C. Fritsch P, et al. Among authors: kerbl r. Pediatr Blood Cancer. 2004 Nov;43(6):679-82. doi: 10.1002/pbc.20126. Pediatr Blood Cancer. 2004. PMID: 15390301

4

Clinical appearance of neuroblastoma 10 years after screening.

Kerbl R, Urban CE, Zotter H, Lackner H, Sovinz P, Ambros PF. Kerbl R, et al. Pediatr Blood Cancer. 2007 Dec;49(7):1012-4. doi: 10.1002/pbc.20828. Pediatr Blood Cancer. 2007. PMID: 16534792

5

Connatal localized neuroblastoma. The case to delay treatment.

Kerbl R, Urban CE, Lackner H, Höfler G, Ambros IM, Ratschek M, Ambros PF. Kerbl R, et al. Cancer. 1996 Apr 1;77(7):1395-401. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1395::AID-CNCR26>3.0.CO;2-W. Cancer. 1996. PMID: 8608521

6

Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.

Kerbl R, Urban CE, Ladenstein R, Ambros IM, Spuller E, Mutz I, Amann G, Kovar H, Gadner H, Ambros PF. Kerbl R, et al. Med Pediatr Oncol. 1997 Jul;29(1):1-10. doi: 10.1002/(sici)1096-911x(199707)29:1<1::aid-mpo1>3.0.co;2-j. Med Pediatr Oncol. 1997. PMID: 9142198

7

Neuroblastoma screening for children: delay, repeat, or delete?

Kerbl R, Urban CE, Ambros IM, Ambros PF. Kerbl R, et al. Med Pediatr Oncol. 1998 Aug;31(2):111-2. doi: 10.1002/(sici)1096-911x(199808)31:2<111::aid-mpo13>3.0.co;2-q. Med Pediatr Oncol. 1998. PMID: 9680938 No abstract available.

8

Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.

Kerbl R, Urban C, Starz I, Ambros IM, Strehl S, Kovar H, Gadner H, Ambros PF. Kerbl R, et al. Med Pediatr Oncol. 1993;21(9):625-6. doi: 10.1002/mpo.2950210902. Med Pediatr Oncol. 1993. PMID: 8412992 No abstract available.

9

Neuroblastoma with focal MYCN amplification and bone marrow infiltration: a staging and treatment dilemma.

Kerbl R, Ambros IM, Ambros PF, Lackner H, Dornbusch HJ, Urban CE. Kerbl R, et al. Med Pediatr Oncol. 2002 Feb;38(2):109-11. doi: 10.1002/mpo.1281. Med Pediatr Oncol. 2002. PMID: 11813175 No abstract available.

10

Interferon alfa-2a in recurrent metastatic hemangiopericytoma.

Lackner H, Urban C, Dornbusch HJ, Schwinger W, Kerbl R, Sovinz P. Lackner H, et al. Among authors: kerbl r. Med Pediatr Oncol. 2003 Mar;40(3):192-4. doi: 10.1002/mpo.10122. Med Pediatr Oncol. 2003. PMID: 12518351 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page